Compile Data Set for Download or QSAR
Report error Found 166 Enz. Inhib. hit(s) with all data for entry = 12924
Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Human)
Kyorin Pharmaceutical

US Patent
LigandPNGBDBM741019(US12304897, Compound 141)
Affinity DataIC50: 3nMAssay Description:Test compounds and 4 nM recombinant human 15-PGDH (R&D systems) in 50 mM Tris-HCl (pH 8.0) containing 0.01% TWEEN 20 (Sigma) and 0.01% bovine gamma g...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/19/2025
Entry Details
US Patent

Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Human)
Kyorin Pharmaceutical

US Patent
LigandPNGBDBM741018(US12304897, Compound 140)
Affinity DataIC50: 3nMAssay Description:Test compounds and 4 nM recombinant human 15-PGDH (R&D systems) in 50 mM Tris-HCl (pH 8.0) containing 0.01% TWEEN 20 (Sigma) and 0.01% bovine gamma g...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/19/2025
Entry Details
US Patent

Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Human)
Kyorin Pharmaceutical

US Patent
LigandPNGBDBM741017(US12304897, Compound 139)
Affinity DataIC50: 3nMAssay Description:Test compounds and 4 nM recombinant human 15-PGDH (R&D systems) in 50 mM Tris-HCl (pH 8.0) containing 0.01% TWEEN 20 (Sigma) and 0.01% bovine gamma g...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/19/2025
Entry Details
US Patent

Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Human)
Kyorin Pharmaceutical

US Patent
LigandPNGBDBM741016(US12304897, Compound 138)
Affinity DataIC50: 3nMAssay Description:Test compounds and 4 nM recombinant human 15-PGDH (R&D systems) in 50 mM Tris-HCl (pH 8.0) containing 0.01% TWEEN 20 (Sigma) and 0.01% bovine gamma g...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/19/2025
Entry Details
US Patent

Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Human)
Kyorin Pharmaceutical

US Patent
LigandPNGBDBM741014(US12304897, Compound 136)
Affinity DataIC50: 3nMAssay Description:Test compounds and 4 nM recombinant human 15-PGDH (R&D systems) in 50 mM Tris-HCl (pH 8.0) containing 0.01% TWEEN 20 (Sigma) and 0.01% bovine gamma g...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/19/2025
Entry Details
US Patent

Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Human)
Kyorin Pharmaceutical

US Patent
LigandPNGBDBM741013(US12304897, Compound 135)
Affinity DataIC50: 3nMAssay Description:Test compounds and 4 nM recombinant human 15-PGDH (R&D systems) in 50 mM Tris-HCl (pH 8.0) containing 0.01% TWEEN 20 (Sigma) and 0.01% bovine gamma g...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/19/2025
Entry Details
US Patent

Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Human)
Kyorin Pharmaceutical

US Patent
LigandPNGBDBM741012(US12304897, Compound 134)
Affinity DataIC50: 3nMAssay Description:Test compounds and 4 nM recombinant human 15-PGDH (R&D systems) in 50 mM Tris-HCl (pH 8.0) containing 0.01% TWEEN 20 (Sigma) and 0.01% bovine gamma g...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/19/2025
Entry Details
US Patent

Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Human)
Kyorin Pharmaceutical

US Patent
LigandPNGBDBM741025(US12304897, Compound 147)
Affinity DataIC50: 3nMAssay Description:Test compounds and 4 nM recombinant human 15-PGDH (R&D systems) in 50 mM Tris-HCl (pH 8.0) containing 0.01% TWEEN 20 (Sigma) and 0.01% bovine gamma g...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/19/2025
Entry Details
US Patent

Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Human)
Kyorin Pharmaceutical

US Patent
LigandPNGBDBM741021(US12304897, Compound 143)
Affinity DataIC50: 3nMAssay Description:Test compounds and 4 nM recombinant human 15-PGDH (R&D systems) in 50 mM Tris-HCl (pH 8.0) containing 0.01% TWEEN 20 (Sigma) and 0.01% bovine gamma g...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/19/2025
Entry Details
US Patent

Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Human)
Kyorin Pharmaceutical

US Patent
LigandPNGBDBM741020(US12304897, Compound 142)
Affinity DataIC50: 3nMAssay Description:Test compounds and 4 nM recombinant human 15-PGDH (R&D systems) in 50 mM Tris-HCl (pH 8.0) containing 0.01% TWEEN 20 (Sigma) and 0.01% bovine gamma g...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/19/2025
Entry Details
US Patent

Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Human)
Kyorin Pharmaceutical

US Patent
LigandPNGBDBM741003(US12304897, Compound 125)
Affinity DataIC50: 3nMAssay Description:Test compounds and 4 nM recombinant human 15-PGDH (R&D systems) in 50 mM Tris-HCl (pH 8.0) containing 0.01% TWEEN 20 (Sigma) and 0.01% bovine gamma g...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/19/2025
Entry Details
US Patent

Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Human)
Kyorin Pharmaceutical

US Patent
LigandPNGBDBM741002(US12304897, Compound 124)
Affinity DataIC50: 3nMAssay Description:Test compounds and 4 nM recombinant human 15-PGDH (R&D systems) in 50 mM Tris-HCl (pH 8.0) containing 0.01% TWEEN 20 (Sigma) and 0.01% bovine gamma g...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/19/2025
Entry Details
US Patent

Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Human)
Kyorin Pharmaceutical

US Patent
LigandPNGBDBM741001(US12304897, Compound 123)
Affinity DataIC50: 3nMAssay Description:Test compounds and 4 nM recombinant human 15-PGDH (R&D systems) in 50 mM Tris-HCl (pH 8.0) containing 0.01% TWEEN 20 (Sigma) and 0.01% bovine gamma g...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/19/2025
Entry Details
US Patent

Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Human)
Kyorin Pharmaceutical

US Patent
LigandPNGBDBM741000(US12304897, Compound 122)
Affinity DataIC50: 3nMAssay Description:Test compounds and 4 nM recombinant human 15-PGDH (R&D systems) in 50 mM Tris-HCl (pH 8.0) containing 0.01% TWEEN 20 (Sigma) and 0.01% bovine gamma g...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/19/2025
Entry Details
US Patent

Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Human)
Kyorin Pharmaceutical

US Patent
LigandPNGBDBM740999(US12304897, Compound 121)
Affinity DataIC50: 3nMAssay Description:Test compounds and 4 nM recombinant human 15-PGDH (R&D systems) in 50 mM Tris-HCl (pH 8.0) containing 0.01% TWEEN 20 (Sigma) and 0.01% bovine gamma g...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/19/2025
Entry Details
US Patent

Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Human)
Kyorin Pharmaceutical

US Patent
LigandPNGBDBM740998(US12304897, Compound 120)
Affinity DataIC50: 3nMAssay Description:Test compounds and 4 nM recombinant human 15-PGDH (R&D systems) in 50 mM Tris-HCl (pH 8.0) containing 0.01% TWEEN 20 (Sigma) and 0.01% bovine gamma g...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/19/2025
Entry Details
US Patent

Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Human)
Kyorin Pharmaceutical

US Patent
LigandPNGBDBM740997(US12304897, Compound 119)
Affinity DataIC50: 3nMAssay Description:Test compounds and 4 nM recombinant human 15-PGDH (R&D systems) in 50 mM Tris-HCl (pH 8.0) containing 0.01% TWEEN 20 (Sigma) and 0.01% bovine gamma g...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/19/2025
Entry Details
US Patent

Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Human)
Kyorin Pharmaceutical

US Patent
LigandPNGBDBM740996(US12304897, Compound 118)
Affinity DataIC50: 3nMAssay Description:Test compounds and 4 nM recombinant human 15-PGDH (R&D systems) in 50 mM Tris-HCl (pH 8.0) containing 0.01% TWEEN 20 (Sigma) and 0.01% bovine gamma g...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/19/2025
Entry Details
US Patent

Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Human)
Kyorin Pharmaceutical

US Patent
LigandPNGBDBM741010(US12304897, Compound 132)
Affinity DataIC50: 3nMAssay Description:Test compounds and 4 nM recombinant human 15-PGDH (R&D systems) in 50 mM Tris-HCl (pH 8.0) containing 0.01% TWEEN 20 (Sigma) and 0.01% bovine gamma g...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/19/2025
Entry Details
US Patent

Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Human)
Kyorin Pharmaceutical

US Patent
LigandPNGBDBM741009(US12304897, Compound 131)
Affinity DataIC50: 3nMAssay Description:Test compounds and 4 nM recombinant human 15-PGDH (R&D systems) in 50 mM Tris-HCl (pH 8.0) containing 0.01% TWEEN 20 (Sigma) and 0.01% bovine gamma g...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/19/2025
Entry Details
US Patent

Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Human)
Kyorin Pharmaceutical

US Patent
LigandPNGBDBM741008(US12304897, Compound 130)
Affinity DataIC50: 3nMAssay Description:Test compounds and 4 nM recombinant human 15-PGDH (R&D systems) in 50 mM Tris-HCl (pH 8.0) containing 0.01% TWEEN 20 (Sigma) and 0.01% bovine gamma g...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/19/2025
Entry Details
US Patent

Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Human)
Kyorin Pharmaceutical

US Patent
LigandPNGBDBM741007(US12304897, Compound 129)
Affinity DataIC50: 3nMAssay Description:Test compounds and 4 nM recombinant human 15-PGDH (R&D systems) in 50 mM Tris-HCl (pH 8.0) containing 0.01% TWEEN 20 (Sigma) and 0.01% bovine gamma g...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/19/2025
Entry Details
US Patent

Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Human)
Kyorin Pharmaceutical

US Patent
LigandPNGBDBM741006(US12304897, Compound 128)
Affinity DataIC50: 3nMAssay Description:Test compounds and 4 nM recombinant human 15-PGDH (R&D systems) in 50 mM Tris-HCl (pH 8.0) containing 0.01% TWEEN 20 (Sigma) and 0.01% bovine gamma g...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/19/2025
Entry Details
US Patent

Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Human)
Kyorin Pharmaceutical

US Patent
LigandPNGBDBM741005(US12304897, Compound 127)
Affinity DataIC50: 3nMAssay Description:Test compounds and 4 nM recombinant human 15-PGDH (R&D systems) in 50 mM Tris-HCl (pH 8.0) containing 0.01% TWEEN 20 (Sigma) and 0.01% bovine gamma g...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/19/2025
Entry Details
US Patent

Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Human)
Kyorin Pharmaceutical

US Patent
LigandPNGBDBM741004(US12304897, Compound 126)
Affinity DataIC50: 3nMAssay Description:Test compounds and 4 nM recombinant human 15-PGDH (R&D systems) in 50 mM Tris-HCl (pH 8.0) containing 0.01% TWEEN 20 (Sigma) and 0.01% bovine gamma g...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/19/2025
Entry Details
US Patent

Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Human)
Kyorin Pharmaceutical

US Patent
LigandPNGBDBM741033(US12304897, Compound 155)
Affinity DataIC50: 3nMAssay Description:Test compounds and 4 nM recombinant human 15-PGDH (R&D systems) in 50 mM Tris-HCl (pH 8.0) containing 0.01% TWEEN 20 (Sigma) and 0.01% bovine gamma g...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/19/2025
Entry Details
US Patent

Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Human)
Kyorin Pharmaceutical

US Patent
LigandPNGBDBM741032(US12304897, Compound 154)
Affinity DataIC50: 3nMAssay Description:Test compounds and 4 nM recombinant human 15-PGDH (R&D systems) in 50 mM Tris-HCl (pH 8.0) containing 0.01% TWEEN 20 (Sigma) and 0.01% bovine gamma g...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/19/2025
Entry Details
US Patent

Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Human)
Kyorin Pharmaceutical

US Patent
LigandPNGBDBM741031(US12304897, Compound 153)
Affinity DataIC50: 3nMAssay Description:Test compounds and 4 nM recombinant human 15-PGDH (R&D systems) in 50 mM Tris-HCl (pH 8.0) containing 0.01% TWEEN 20 (Sigma) and 0.01% bovine gamma g...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/19/2025
Entry Details
US Patent

Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Human)
Kyorin Pharmaceutical

US Patent
LigandPNGBDBM741030(US12304897, Compound 152)
Affinity DataIC50: 3nMAssay Description:Test compounds and 4 nM recombinant human 15-PGDH (R&D systems) in 50 mM Tris-HCl (pH 8.0) containing 0.01% TWEEN 20 (Sigma) and 0.01% bovine gamma g...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/19/2025
Entry Details
US Patent

Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Human)
Kyorin Pharmaceutical

US Patent
LigandPNGBDBM741029(US12304897, Compound 151)
Affinity DataIC50: 3nMAssay Description:Test compounds and 4 nM recombinant human 15-PGDH (R&D systems) in 50 mM Tris-HCl (pH 8.0) containing 0.01% TWEEN 20 (Sigma) and 0.01% bovine gamma g...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/19/2025
Entry Details
US Patent

Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Human)
Kyorin Pharmaceutical

US Patent
LigandPNGBDBM741028(US12304897, Compound 150)
Affinity DataIC50: 3nMAssay Description:Test compounds and 4 nM recombinant human 15-PGDH (R&D systems) in 50 mM Tris-HCl (pH 8.0) containing 0.01% TWEEN 20 (Sigma) and 0.01% bovine gamma g...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/19/2025
Entry Details
US Patent

Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Human)
Kyorin Pharmaceutical

US Patent
LigandPNGBDBM741043(US12304897, Compound 165)
Affinity DataIC50: 3nMAssay Description:Test compounds and 4 nM recombinant human 15-PGDH (R&D systems) in 50 mM Tris-HCl (pH 8.0) containing 0.01% TWEEN 20 (Sigma) and 0.01% bovine gamma g...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/19/2025
Entry Details
US Patent

Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Human)
Kyorin Pharmaceutical

US Patent
LigandPNGBDBM741042(US12304897, Compound 164)
Affinity DataIC50: 3nMAssay Description:Test compounds and 4 nM recombinant human 15-PGDH (R&D systems) in 50 mM Tris-HCl (pH 8.0) containing 0.01% TWEEN 20 (Sigma) and 0.01% bovine gamma g...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/19/2025
Entry Details
US Patent

Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Human)
Kyorin Pharmaceutical

US Patent
LigandPNGBDBM741041(US12304897, Compound 163)
Affinity DataIC50: 3nMAssay Description:Test compounds and 4 nM recombinant human 15-PGDH (R&D systems) in 50 mM Tris-HCl (pH 8.0) containing 0.01% TWEEN 20 (Sigma) and 0.01% bovine gamma g...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/19/2025
Entry Details
US Patent

Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Human)
Kyorin Pharmaceutical

US Patent
LigandPNGBDBM741040(US12304897, Compound 162)
Affinity DataIC50: 3nMAssay Description:Test compounds and 4 nM recombinant human 15-PGDH (R&D systems) in 50 mM Tris-HCl (pH 8.0) containing 0.01% TWEEN 20 (Sigma) and 0.01% bovine gamma g...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/19/2025
Entry Details
US Patent

Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Human)
Kyorin Pharmaceutical

US Patent
LigandPNGBDBM741039(US12304897, Compound 161)
Affinity DataIC50: 3nMAssay Description:Test compounds and 4 nM recombinant human 15-PGDH (R&D systems) in 50 mM Tris-HCl (pH 8.0) containing 0.01% TWEEN 20 (Sigma) and 0.01% bovine gamma g...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/19/2025
Entry Details
US Patent

Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Human)
Kyorin Pharmaceutical

US Patent
LigandPNGBDBM741038(US12304897, Compound 160)
Affinity DataIC50: 3nMAssay Description:Test compounds and 4 nM recombinant human 15-PGDH (R&D systems) in 50 mM Tris-HCl (pH 8.0) containing 0.01% TWEEN 20 (Sigma) and 0.01% bovine gamma g...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/19/2025
Entry Details
US Patent

Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Human)
Kyorin Pharmaceutical

US Patent
LigandPNGBDBM741037(US12304897, Compound 159)
Affinity DataIC50: 3nMAssay Description:Test compounds and 4 nM recombinant human 15-PGDH (R&D systems) in 50 mM Tris-HCl (pH 8.0) containing 0.01% TWEEN 20 (Sigma) and 0.01% bovine gamma g...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/19/2025
Entry Details
US Patent

Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Human)
Kyorin Pharmaceutical

US Patent
LigandPNGBDBM741036(US12304897, Compound 158)
Affinity DataIC50: 3nMAssay Description:Test compounds and 4 nM recombinant human 15-PGDH (R&D systems) in 50 mM Tris-HCl (pH 8.0) containing 0.01% TWEEN 20 (Sigma) and 0.01% bovine gamma g...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/19/2025
Entry Details
US Patent

Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Human)
Kyorin Pharmaceutical

US Patent
LigandPNGBDBM740888(US12304897, Compound 10)
Affinity DataIC50: 3nMAssay Description:Test compounds and 4 nM recombinant human 15-PGDH (R&D systems) in 50 mM Tris-HCl (pH 8.0) containing 0.01% TWEEN 20 (Sigma) and 0.01% bovine gamma g...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/19/2025
Entry Details
US Patent

Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Human)
Kyorin Pharmaceutical

US Patent
LigandPNGBDBM740887(US12304897, Compound 9)
Affinity DataIC50: 3nMAssay Description:Test compounds and 4 nM recombinant human 15-PGDH (R&D systems) in 50 mM Tris-HCl (pH 8.0) containing 0.01% TWEEN 20 (Sigma) and 0.01% bovine gamma g...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/19/2025
Entry Details
US Patent

Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Human)
Kyorin Pharmaceutical

US Patent
LigandPNGBDBM740886(US12304897, Compound 8)
Affinity DataIC50: 3nMAssay Description:Test compounds and 4 nM recombinant human 15-PGDH (R&D systems) in 50 mM Tris-HCl (pH 8.0) containing 0.01% TWEEN 20 (Sigma) and 0.01% bovine gamma g...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/19/2025
Entry Details
US Patent

Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Human)
Kyorin Pharmaceutical

US Patent
LigandPNGBDBM740884(US12304897, Compound 6)
Affinity DataIC50: 3nMAssay Description:Test compounds and 4 nM recombinant human 15-PGDH (R&D systems) in 50 mM Tris-HCl (pH 8.0) containing 0.01% TWEEN 20 (Sigma) and 0.01% bovine gamma g...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/19/2025
Entry Details
US Patent

Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Human)
Kyorin Pharmaceutical

US Patent
LigandPNGBDBM740899(US12304897, Compound 21)
Affinity DataIC50: 3nMAssay Description:Test compounds and 4 nM recombinant human 15-PGDH (R&D systems) in 50 mM Tris-HCl (pH 8.0) containing 0.01% TWEEN 20 (Sigma) and 0.01% bovine gamma g...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/19/2025
Entry Details
US Patent

Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Human)
Kyorin Pharmaceutical

US Patent
LigandPNGBDBM740897(US12304897, Compound 19)
Affinity DataIC50: 3nMAssay Description:Test compounds and 4 nM recombinant human 15-PGDH (R&D systems) in 50 mM Tris-HCl (pH 8.0) containing 0.01% TWEEN 20 (Sigma) and 0.01% bovine gamma g...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/19/2025
Entry Details
US Patent

Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Human)
Kyorin Pharmaceutical

US Patent
LigandPNGBDBM740896(US12304897, Compound 18)
Affinity DataIC50: 3nMAssay Description:Test compounds and 4 nM recombinant human 15-PGDH (R&D systems) in 50 mM Tris-HCl (pH 8.0) containing 0.01% TWEEN 20 (Sigma) and 0.01% bovine gamma g...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/19/2025
Entry Details
US Patent

Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Human)
Kyorin Pharmaceutical

US Patent
LigandPNGBDBM740895(US12304897, Compound 17)
Affinity DataIC50: 3nMAssay Description:Test compounds and 4 nM recombinant human 15-PGDH (R&D systems) in 50 mM Tris-HCl (pH 8.0) containing 0.01% TWEEN 20 (Sigma) and 0.01% bovine gamma g...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/19/2025
Entry Details
US Patent

Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Human)
Kyorin Pharmaceutical

US Patent
LigandPNGBDBM740893(US12304897, Compound 15)
Affinity DataIC50: 3nMAssay Description:Test compounds and 4 nM recombinant human 15-PGDH (R&D systems) in 50 mM Tris-HCl (pH 8.0) containing 0.01% TWEEN 20 (Sigma) and 0.01% bovine gamma g...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/19/2025
Entry Details
US Patent

Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Human)
Kyorin Pharmaceutical

US Patent
LigandPNGBDBM740892(US12304897, Compound 14)
Affinity DataIC50: 3nMAssay Description:Test compounds and 4 nM recombinant human 15-PGDH (R&D systems) in 50 mM Tris-HCl (pH 8.0) containing 0.01% TWEEN 20 (Sigma) and 0.01% bovine gamma g...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/19/2025
Entry Details
US Patent

Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Human)
Kyorin Pharmaceutical

US Patent
LigandPNGBDBM740883(US12304897, Compound 5)
Affinity DataIC50: 3nMAssay Description:Test compounds and 4 nM recombinant human 15-PGDH (R&D systems) in 50 mM Tris-HCl (pH 8.0) containing 0.01% TWEEN 20 (Sigma) and 0.01% bovine gamma g...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/19/2025
Entry Details
US Patent

Displayed 1 to 50 (of 166 total ) | Next | Last >>
Jump to: